News Focus
News Focus
icon url

TheDane

03/18/16 1:17 PM

#142412 RE: Yooper61 #142411

Maybe he's just being cautious.
icon url

I Need Help

03/18/16 1:17 PM

#142413 RE: Yooper61 #142411

I would love to be the fly on Leo's wall. Ooops, that might be considered insider trading.

My best guess to your question is that it may be too early, even for raw data analysis.

As I previously said, even if confident Leo would not make any definitive statement until the data is finalized

But, can one make anything of his confident non definitive statements? Probably, yes. Based on Leo's past behavior and communications regarding CTIX's science.
icon url

MinnieM

03/18/16 2:49 PM

#142446 RE: Yooper61 #142411

The control arm in the Brilacidin ph IIb ABSSSI trial was another drug.

The control arm in the Prurisol ph II psoriasis trial is a placebo. Psoriasis ebbs and flows on it's own and also responds to placebo. Plus, there are about half the patient number in over double the trial locations. It couldn't be done realistically or he would have. Leo loves informing shareholders whenever possible.





In Reply to 'Yooper61'

I wonder why Leo didn't give us a PR like he did when B 2b concluded? Both trials had 3 treatment arms and 1 control arm. He knew then. You would think he'd know now.